To evaluate the efficacy of omega-3 fatty acid (O3FA) supplementation in the treatment of COVID-related olfactory dysfunction (OD).
Methods
Patients with laboratory-confirmed or clinically-suspected COVID-19 infection and new-onset OD from August 2020 to November 2021 were prospectively recruited. Patients with quantitative OD, defined as a brief smell identification test (BSIT) score of 9 or less, were eligible for study inclusion. The experimental group received 2 g of O3FA supplementation, while the control group received an identical placebo to be taken daily for 6 weeks. The primary outcome was a change in BSIT score between the initial and 6-week follow-up tests.
Results
One hundred and seventeen patients were included in the analysis, including 57 patients in the O3FA group and 60 in the placebo group. O3FA group patients demonstrated a mean BSIT improvement of 1.12 ± 1.99 compared to 0.68 ± 1.86 in the placebo group (p = 0.221). Seventy-seven patients, 42 within the O3FA group and 35 in the placebo group, completed a follow-up BSIT survey at an average of 717.8 days from study onset. At long-term follow-up, there was an average BSIT score improvement of 1.72 within the O3FA group compared to 1.76 within the placebo group (p = 0.948).
Conclusion
Among patients with persistent COVID-related OD, our study showed no clear evidence of relative short-term or long-term olfactory recovery among patients receiving high doses of O3FA supplementation.
VairaLASalzanoGDeianaGDe RiuG. Anosmia and Ageusia: common findings in COVID-19 patients. The Laryngoscope. 2020;130(7):1787.
2.
LechienJRChiesa-EstombaCMDe SiatiDR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261.
3.
MoeinSTHashemianSMMansourafsharB, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10(8):944–950.
4.
KlopfensteinTKadiane-OussouNJTokoL, et al. Features of anosmia in COVID-19. Médecine Mal Infect. 2020;50(5):436–439.
5.
SolerZMPatelZMTurnerJHHolbrookEH. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol. 2020;10(7):814–820.
6.
D'AscanioLPandolfiniMCingolaniC, et al. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell. Otolaryngol Neck Surg. 2021;164(1):82–86.
7.
MengXDengYDaiZMengZ. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581.
8.
SpinatoGFabbrisCPoleselJ, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323(20):2089.
9.
YanCHFarajiFPrajapatiDPBooneCEDeCondeAS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806–813.
10.
GiacomelliAPezzatiLContiF, et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. 2020;71(15):889–890.
11.
BagheriSHAsghariAFarhadiM, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran. 2020;34(1):62.
12.
SpethMMSinger-CorneliusTOberleMGenglerIBrockmeierSJSedaghatAR.Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics. Otolaryngol Neck Surg. 2020;163(1):114–120.
HopkinsCSurdaPWhiteheadEKumarBN. Early recovery following new onset anosmia during the COVID-19 pandemic – an observational cohort study. J Otolaryngol Head Neck Surg. 2020;49(1):26.
15.
Chiesa-Estomba CM, Lechien JR, Radulesco T, et al. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol.2020;27(11):2318–2321.
16.
LevyJM. Treatment recommendations for persistent smell and taste dysfunction following COVID-19—the coming deluge. JAMA Otolaryngol Neck Surg. 2020;146(8):733.
17.
Boscolo-RizzoPGuidaFPoleselJ, et al. Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study. Eur Arch Otorhinolaryngol. 2022;279(1):515–520.
18.
KaramaliKElliottMHopkinsC. COVID-19 related olfactory dysfunction. Curr Opin Otolaryngol Head Neck Surg. 2022;30(1):19–25.
19.
LernerDKGarveyKL, Arrighi-Allisan AE, et al. Clinical features of parosmia associated with COVID -19 infection. The Laryngoscope. 2022;132(3):633–639.
20.
BonfilsPAvanPFaulconPMalinvaudD. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol Neck Surg. 2005;131(2):107.
21.
ParmaVOhlaKVeldhuizenMG, et al. More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020;45(7):609–622.
22.
Sayinİ, Yaşar KK, Yazici ZM. Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study. Otolaryngol Neck Surg.2020;163(3):473–479.
23.
XydakisMSAlbersMWHolbrookEH, et al. Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol. 2021;20(9):753–761.
24.
NetaFIFernandesACLValeAJM, et al. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Curr Res Pharmacol Drug Discov. 2021;2(1):100035.
25.
BilinskaKJakubowskaPVon BartheldCSButowtR. Expression of the SARS-CoV-2 entry proteins, ACE2and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with Age. ACS Chem Neurosci. 2020;11(11):1555–1562.
26.
BrannDHTsukaharaTWeinrebC, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv.2020;6(31):eabc5801.
27.
ZazhytskaMKodraAHoaglandDA, et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell.2022;185(6):1052–1064.e12.
28.
TsivgoulisGFragkouPCLachanisS, et al. Olfactory bulb and mucosa abnormalities in persistent COVID-19-induced anosmia: a magnetic resonance imaging study. Eur J Neurol [Internet]. 2021 Jan [cited 2023 May 8];28(1). Available from: https://onlinelibrary.wiley.com/doi/10.1111/ene.14537
29.
WhitcroftKLHummelT. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA. 2020;323(24):2512.
30.
WhitcroftKLHummelT. Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Neck Surg. 2019;145(9):846.
31.
HopkinsCAlaninMPhilpottC, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol.2021;46(1):16–22.
32.
AddisonABWongBAhmedT, et al. Clinical olfactory working group consensus statement on the treatment of postinfectious olfactory dysfunction. J Allergy Clin Immunol.2021;147(5):1704–1719.
33.
Le BonSDKonopnickiDPisarskiNPrunierLLechienJRHoroiM. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol.2021;278(8):3113–3117.
34.
AltundagAYilmazEKesimliMC. Modified olfactory training is an effective treatment Method for COVID-19 induced parosmia. The Laryngoscope. 2022;132(7):1433–1438.
35.
AbdelalimAAMohamadyAAElsayedRAElawadyMAGhallabAF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. Am J Otolaryngol. 2021;42(2):102884.
36.
KhaniEKhialiSBeheshtirouySEntezari-MalekiT. Potential pharmacologic treatments for COVID-19 smell and taste loss: a comprehensive review. Eur J Pharmacol. 2021;912(1):174582.
37.
CalderPC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105–1115.
38.
FigueroaJDDe LeonM. Neurorestorative targets of dietary long-chain Omega-3 fatty acids in neurological injury. Mol Neurobiol. 2014;50(1):197–213.
39.
GopinathBSueCMFloodVMBurlutskyGMitchellP. Dietary intakes of fats, fish and nuts and olfactory impairment in older adults. Br J Nutr.2015;114(2):240–247.
GladmanSJHuangWLimSN, et al. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids. J Neurosci. 2012;32(2):563–571.
42.
YanCHRathorAKrookK, et al. Effect of Omega-3 supplementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection: a multicenter prospective randomized controlled trial. Neurosurgery. 2020;87(2):E91–E98.
43.
El RassiEMaceJCSteeleTO, et al. Sensitivity analysis and diagnostic accuracy of the Brief Smell Identification Test in patients with chronic rhinosinusitis: sensitivity analysis of the BSIT in CRS. Int Forum Allergy Rhinol. 2016;6(3):287–292.
44.
MattosJLEdwardsCSchlosserRJ, et al. A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol.2019;9(10):1144–1150.
45.
SimopoulosEKatotomichelakisMGouverisHTripsianisGLivaditisMDanielidesV. Olfaction-associated quality of life in chronic rhinosinusitis: adaptation and validation of an olfaction-specific questionnaire. The Laryngoscope. 2012;122(7):1450–1454.
46.
HopkinsCGillettSSlackRLundVJBrowneJP. Psychometric validity of the 22-item Sinonasal outcome test. Clin Otolaryngol. 2009;34(5):447–454.
47.
LevyJMMaceJCBodnerTEAltJASmithTL. Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis: defining olfactory measures in CRS. Int Forum Allergy Rhinol. 2017;7(8):821–826.
48.
SchoberPVetterTR. Repeated measures designs and analysis of longitudinal data: if at first you do not succeed—try, try again. Anesth Analg. 2018;127(2):569–575.
49.
ParkerAMBrighamEConnollyB, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328–1341.
50.
HernandezAKWooschDHaehnerAHummelT. Omega-3 supplementation in postviral olfactory dysfunction: a pilot study. Rhinol J.2022.
51.
Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. ‘Sniffin’ Sticks’: olfactory performance assessed by the combined testing of odour identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22(1):39–52.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
